It's a good idea from the perspective of RVX shareholders, since RVX has not been able to convince literally anyone else to fund the BOM2/CORAL trials.

It's a bad idea from the perspective of Zenith shareholders, especially those who hold no interest in RVX.

There may be legitimate arguments in favour of the merger; i.e. success by RVX means profit for Zenith.

But the downside risk is Zenith is now carrying RVX and if the trial fails, both companies will be looking at insolvency.

Whereas, without the merger, Zenith's future looks very bright.

So: do you trust this team to properly design a trial for success? There's your answer.